Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

Delayed Data
As of Sep 25
 -0.43 / -0.87%
Today’s Change
Today|||52-Week Range
Oramed Now Has a Clear Path to Market With Oral Insulin
Sep 22 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Apple, Pfizer, Carnival, T. Rowe Price and Novo No...
Sep 14 / Zacks.com - Paid Partner Content
Pfizer's Sutent Label Expansion Gets Mixed FDA Committee View
Sep 20 / Zacks.com - Paid Partner Content
Top Analyst Reports for Apple, Pfizer & Carnival
Sep 13 / Zacks.com - Paid Partner Content